Table 2 Study Measures
Measures, Constructs, and Indicators | ||
|---|---|---|
Construct | Measure | Operational Indicator |
Sample Characterization/Exploratory Moderators | ||
Cognition | BACS (Baseline only) | Total Score |
Functional Capacity | VRFCAT (Baseline only) | Total Score |
Psychotic Symptoms | PANSS Positive and Negative | Total Score |
Depressive Symptoms | Calgary Depression Scale (CDSS) | Total Score |
Treatment Expectancies | Credibility/Expectancy Questionnaire (CEQ) | Total Score |
Primary outcome: Trained Task-Based IA Target (R61,R33) | ||
Trained Task-based IA | IA on METER and VLMT | Estimated vs Actual correct |
Primary outcome: Transfer of Training Target (R61, R33) | ||
Untrained Task-based IA | Metacognitive WCST | Global resolution score |
Functional outcomes (Exploratory in R61; R33) | ||
Functional Outcome | Informant-Rated SLOF | Total Score |
Secondary Outcomes | ||
Life space Mobility | GPS | Daily distance from home |
Exploratory Mechanisms | ||
Strategy Use; Motivation and Defeatist Beliefs | Compensatory Cognitive Strategies Scale; CAINS Motivation, Defeatist Performance Beliefs | Total scores |
Acceptability and Side Effects | ||
Intervention Satisfaction | Client Satisfaction Questionnaire (CSQ) | Total Score |
User Engagement | Trials and Coaching Sessions Completed | % of Total Possible |
Adverse Reactions | Negative Effects Questionnaire (NEQ) | Total Score |
